Skip to content
PanaceaPharmaceutical Solutions

Boutique CRO · Phases 1–4

The protocol is only as strong as the site that runs it.

Panacea is a principal-led CRO and consulting practice. Sponsors, partner CROs, and investigator sites come here for end-to-end site operations — feasibility through closeout — held to a pharmacist’s standard.

Start a conversationView services
Marble architectural fragment and a shallow Greek kylix on dark teal linen

6+

Years in research

7

Investigator sites

50+

Studies executed

I–IV

Phases in scope

Who we work with

Built for the three rooms where a trial actually lives.

Sponsors & biotech

A principal, not a staffing layer.

You work with the person who has run the site — feasibility through closeout — not a rotating bench of account managers.

Partner CROs

Overflow that already knows the site side.

When a protocol needs extra operational depth, Panacea slots in as senior site-ops capacity without a long ramp.

Investigator sites

Startup, equipment, execution, closeout.

Hands-on support for the parts of a trial that stall a site: binders, vendors, training, monitoring readiness, and a clean close.

How an engagement runs

Feasibility to closeout. Nothing theatrical in between.

Full service list

  1. 01

    Feasibility

    Protocol fit, enrollment realism, competing trials, and whether the site can actually run the visit schedule — before anyone wastes a startup cycle.

  2. 02

    Startup

    Regulatory packets, essential documents, equipment acquisition, vendor setup, and training so first-patient-in is an operational fact, not a slide.

  3. 03

    Execution

    Day-to-day site operations, monitoring, data flow, deviation handling, and the unglamorous work that keeps a Phase 2 or 3 from drifting.

  4. 04

    Closeout

    ISF reconciliation, query resolution, investigational product accountability, and a close that will stand up to a monitor, an auditor, or an inspector.

Therapeutic range

Broad Therapeutic Reach, Proven in Practice

From Alzheimer’s and Crohn’s disease to breast and lung cancer, COPD, asthma, psoriasis, eczema, heart failure, hypertension, high cholesterol, and immunizations, our therapeutic experience covers a wide range of indications — extending into rare disease work as well. That coverage spans early- and late-phase trials alike, giving our team firsthand familiarity with the protocol design, endpoint definitions, and patient population nuances specific to each area.

See experience

  • Oncology

  • Neurology

  • Gastroenterology

  • Vaccines

  • Pulmonology

  • Dermatology

  • Cardiology

  • Pain

  • Gene therapy

Principal

Justin Donovan, PharmD

Licensed pharmacist. More than six years of hands-on clinical research across seven sites and 50+ studies. The practice is boutique on purpose: the person who takes the call is the person who has run the work.

GCP · HSP · IATA

About Panacea
Clinical desk still life with a protocol binder, glass ampoule, and fountain pen

Next step

Tell us what you are standing up. We will tell you if we are the right fit.

No business-development theater. A direct note to the principal is enough.

Inquire